0001552622-17-000001.txt : 20170502 0001552622-17-000001.hdr.sgml : 20170502 20170501202753 ACCESSION NUMBER: 0001552622-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170502 DATE AS OF CHANGE: 20170501 EFFECTIVENESS DATE: 20170502 FILER: COMPANY DATA: COMPANY CONFORMED NAME: InCarda Therapeutics, Inc. CENTRAL INDEX KEY: 0001552622 IRS NUMBER: 264521716 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-285853 FILM NUMBER: 17802604 BUSINESS ADDRESS: STREET 1: 530 LYTTON AVE CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 408-219-2576 MAIL ADDRESS: STREET 1: 530 LYTTON AVE CITY: PALO ALTO STATE: CA ZIP: 94301 D 1 primary_doc.xml X0707 D LIVE 0001552622 InCarda Therapeutics, Inc. 150 North Hill Drive #24 Brisbane CA CALIFORNIA 94005 408-219-2576 DELAWARE Pleiades Cardio-Therapeutics, Inc. None Corporation true Rangachari Narasimhan 150 North Hill Drive #24 Brisbane CA CALIFORNIA 94005 Executive Officer Director Grace Colon 150 North Hill Drive #24 Brisbane CA CALIFORNIA 94005 Executive Officer Director McCarthy Reenie 150 North Hill Drive #24 Brisbane CA CALIFORNIA 94005 Director Bischofberger Norbert 150 North Hill Drive #24 Brisbane CA CALIFORNIA 94005 Director Miller Samantha 150 North Hill Drive #24 Brisbane CA CALIFORNIA 94005 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2017-03-09 false true true true false 5000 2500000 2135000 365000 false 16 0 0 0 Proceeds to be used as working capital, including payment of director, officer and employee salaries. false InCarda Therapeutics, Inc. /s/Grace Colon Grace Colon CEO and President 2017-04-27